Proteome-Wide Protein Expression Profiling Across Five Pancreatic Cell Lines
暂无分享,去创建一个
[1] Prasenjit Dey,et al. Genetics and biology of pancreatic ductal adenocarcinoma , 2006, Genes & development.
[2] A. Jemal,et al. Cancer statistics, 2016 , 2016, CA: a cancer journal for clinicians.
[3] B. Spiegelman,et al. Detection and Quantitation of Circulating Human Irisin by Tandem Mass Spectrometry. , 2015, Cell metabolism.
[4] Steven P Gygi,et al. Global Analysis of Protein Expression and Phosphorylation Levels in Nicotine-Treated Pancreatic Stellate Cells. , 2015, Journal of proteome research.
[5] Bruno Domon,et al. Large-Scale Targeted Proteomics Using Internal Standard Triggered-Parallel Reaction Monitoring (IS-PRM)* , 2015, Molecular & Cellular Proteomics.
[6] Alexander S. Banks,et al. Effects of MEK inhibitors GSK1120212 and PD0325901 in vivo using 10‐plex quantitative proteomics and phosphoproteomics , 2015, Proteomics.
[7] S. Gygi,et al. A comprehensive proteomic and phosphoproteomic analysis of yeast deletion mutants of 14‐3‐3 orthologs and associated effects of rapamycin , 2015, Proteomics.
[8] Damon H. May,et al. Proteins associated with pancreatic cancer survival in patients with resectable pancreatic ductal adenocarcinoma , 2014, Laboratory Investigation.
[9] Edward L. Huttlin,et al. MultiNotch MS3 Enables Accurate, Sensitive, and Multiplexed Detection of Differential Expression across Cancer Cell Line Proteomes , 2014, Analytical chemistry.
[10] Akhilesh Pandey,et al. Heterogeneity of Pancreatic Cancer Metastases in a Single Patient Revealed by Quantitative Proteomics* , 2014, Molecular & Cellular Proteomics.
[11] Adele Bourmaud,et al. Technical considerations for large-scale parallel reaction monitoring analysis. , 2014, Journal of proteomics.
[12] R. Pirola,et al. Stars and stripes in pancreatic cancer: role of stellate cells and stroma in cancer progression , 2014, Front. Physiol..
[13] M. Donadelli,et al. Comparative proteomic and phosphoproteomic profiling of pancreatic adenocarcinoma cells treated with CB1 or CB2 agonists , 2013, Electrophoresis.
[14] Joe R. Cannon,et al. Mass-biased partitioning to enhance middle down proteomics analysis. , 2013, Journal of mass spectrometry : JMS.
[15] Anushya Muruganujan,et al. PANTHER in 2013: modeling the evolution of gene function, and other gene attributes, in the context of phylogenetic trees , 2012, Nucleic Acids Res..
[16] Edward L. Huttlin,et al. Increasing the multiplexing capacity of TMTs using reporter ion isotopologues with isobaric masses. , 2012, Analytical chemistry.
[17] Derek J. Bailey,et al. Parallel Reaction Monitoring for High Resolution and High Mass Accuracy Quantitative, Targeted Proteomics* , 2012, Molecular & Cellular Proteomics.
[18] Steven P Gygi,et al. Hyperplexing: A Method for Higher-Order Multiplexed Quantitative Proteomics Provides a Map of the Dynamic Response to Rapamycin in Yeast , 2012, Science Signaling.
[19] H. Steen,et al. Mass Spectrometry-Based Proteomics for Translational Research: A Technical Overview , 2012, The Yale journal of biology and medicine.
[20] H. Steen,et al. Proteomic analysis of a rat pancreatic stellate cell line using liquid chromatography tandem mass spectrometry (LC-MS/MS). , 2011, Journal of proteomics.
[21] H. Steen,et al. Proteomic analysis of an immortalized mouse pancreatic stellate cell line identifies differentially-expressed proteins in activated vs nonproliferating cell states. , 2011, Journal of proteome research.
[22] P. Spellman,et al. Subtypes of Pancreatic Ductal Adenocarcinoma and Their Differing Responses to Therapy , 2011, Nature Medicine.
[23] Edward L. Huttlin,et al. A Tissue-Specific Atlas of Mouse Protein Phosphorylation and Expression , 2010, Cell.
[24] Min Zhang,et al. Membrane proteomic analysis of pancreatic cancer cells , 2010, Journal of Biomedical Science.
[25] Joe R. Cannon,et al. High-throughput middle-down analysis using an orbitrap. , 2010, Journal of proteome research.
[26] J. Shea,et al. Phenotype and Genotype of Pancreatic Cancer Cell Lines , 2010, Pancreas.
[27] Joshua E. Elias,et al. Target-Decoy Search Strategy for Mass Spectrometry-Based Proteomics , 2010, Proteome Bioinformatics.
[28] H. Kocher,et al. Analysis of mortality rates for pancreatic cancer across the world. , 2008, HPB : the official journal of the International Hepato Pancreato Biliary Association.
[29] Richard D. Smith,et al. Does trypsin cut before proline? , 2008, Journal of proteome research.
[30] Steven P Gygi,et al. Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry , 2007, Nature Methods.
[31] P. Fabri,et al. HPAC, a new human glucocorticoid-sensitive pancreatic ductal adenocarcinoma cell line , 1994, In Vitro Cellular & Developmental Biology - Animal.
[32] Steven P Gygi,et al. A probability-based approach for high-throughput protein phosphorylation analysis and site localization , 2006, Nature Biotechnology.
[33] J. Kleeff,et al. Immortalization of pancreatic stellate cells as an in vitro model of pancreatic fibrosis: deactivation is induced by matrigel and N-acetylcysteine , 2005, Laboratory Investigation.
[34] M. Hollingsworth,et al. Notch2-positive progenitors with the intrinsic ability to give rise to pancreatic ductal cells , 2005, Laboratory Investigation.
[35] K. Parker,et al. Multiplexed Protein Quantitation in Saccharomyces cerevisiae Using Amine-reactive Isobaric Tagging Reagents*S , 2004, Molecular & Cellular Proteomics.
[36] M. Mann,et al. Properties of 13C-substituted arginine in stable isotope labeling by amino acids in cell culture (SILAC). , 2003, Journal of proteome research.
[37] Andrew H. Thompson,et al. Tandem mass tags: a novel quantification strategy for comparative analysis of complex protein mixtures by MS/MS. , 2003, Analytical chemistry.
[38] G A Colditz,et al. A prospective study of cigarette smoking and the risk of pancreatic cancer. , 1996, Archives of internal medicine.
[39] P. Jekel,et al. Use of endoproteinase Lys-C from Lysobacter enzymogenes in protein sequence analysis. , 1983, Analytical biochemistry.
[40] T. Orfeo,et al. One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice. , 1977, Journal of the National Cancer Institute.
[41] M. Lieber,et al. Establishment of a continuous tumor‐cell line (PANC‐1) from a human carcinoma of the exocrine pancreas , 1975, International journal of cancer.